ATOSSA THERAPEUTICS, INC.

ATOS - CIK 0001488039

Market cap-

Rank-

SEC filings634

ATOS income statement (quarterly)

The table below shows ATOSSA THERAPEUTICS, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.

Line item	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024
Revenue	-	-	-	-	-	-
Cost of revenue	-	-	-	-	-	-
Gross profit	-	-	-	-	-	-
R&D	$4.78M	$5.37M	$5.50M	$4.16M	$3.41M	$3.55M
SG&A

ATOS annual revenue (10-K history)

ATOSSA THERAPEUTICS, INC. reported annual revenue of $1.76K for fiscal year 2015. That is down 95.6% from $40.14K in fiscal 2014. Over the 5 fiscal years shown, annual revenue grew from $1.50K (FY 2011) to $1.76K. Figures come from the company's audited annual reports as filed with the SEC.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.